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ARTICLE
Quantitative structural mechanobiology of platelet-
driven blood clot contraction
Oleg V. Kim1,2,3,4, Rustem I. Litvinov1,5, Mark S. Alber2,4,6 & John W. Weisel1
Blood clot contraction plays an important role in prevention of bleeding and in thrombotic
disorders. Here, we unveil and quantify the structural mechanisms of clot contraction at the
level of single platelets. A key elementary step of contraction is sequential extension–
retraction of platelet filopodia attached to fibrin fibers. In contrast to other cell–matrix sys-
tems in which cells migrate along fibers, the “hand-over-hand” longitudinal pulling causes
shortening and bending of platelet-attached fibers, resulting in formation of fiber kinks. When
attached to multiple fibers, platelets densify the fibrin network by pulling on fibers trans-
versely to their longitudinal axes. Single platelets and aggregates use actomyosin contractile
machinery and integrin-mediated adhesion to remodel the extracellular matrix, inducing
compaction of fibrin into bundled agglomerates tightly associated with activated platelets.
The revealed platelet-driven mechanisms of blood clot contraction demonstrate an important
new biological application of cell motility principles.
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Contraction of blood clots and thrombi is an inter-disciplinary problem related to fundamental aspects of cellbiology, including cell motility and interaction of cells
with extracellular matrix, as well as to blood clotting and its
disorders, such as heart attack, stroke, and venous thromboem-
bolism. Platelet-driven clot contraction is important for hemos-
tasis and wound healing as well as for restoring the blood flow
past otherwise obstructive thrombi within a vessel1. In a more
general context, the ability of cells to contract is an essential
biological function of various biological systems, including mus-
cle cells, endothelial cells, hepatic stellate cells, fibroblasts, and
activated platelets utilizing the same intracellular contractile
protein machinery2–5. Non-muscle myosin IIA is critical for
platelet contraction by interacting with actin to form a contractile
unit similar to other actomyosins in cell motility. The platelet
integrin αIIbβ3 forms a transmembrane link between fibrin out-
side the platelet and actin inside the platelet6, 7 connected to the
integrin via talin8–10.
The studies described so far define the components necessary
for clot contraction, but the physical mechanism has still been
unknown. While it has been demonstrated that platelets and
fibrin are necessary for contraction of clots, which has been
studied at different special scales from a whole clot to the single-
cell level11–16, much less is known about how individual platelets
or small platelet aggregates exert contractile force on individual
fibrin fibers and how this tension causes collapse of the entire
filamentous network and reduction of clot volume. To get
insights into the structural reorganization of the extracellular
matrix underlying platelet-driven clot contraction biomechanics,
we use high-resolution confocal microscopy and rheometry to
perform concurrent three-dimensional (3D) dynamic structural
and mechanical measurements of the platelet-fibrin meshwork
over the course of clot contraction. We pay special attention to
the elementary steps of clot contraction in the real-time scale by
visualizing single contracting platelets bound to an individual
fibrin fiber and their effects on remodeling of the entire fibrin
network powered by multiple contracting platelets. We discover a
structural mechanism by which local platelet-fibrin interactions
result in dramatic modifications of the whole clot architecture.
Results
Platelets bend and shorten individual fibrin fibers. To deter-
mine the biomechanical mechanisms that drive contraction of
blood clots, we performed time-lapse (50 min) high-resolution z-
stack imaging of the contracting platelet-fibrin meshwork, which
enabled us to watch spatio-temporal structural rearrangements of
single fibers attached to individual platelets or their small
aggregates ( ~ 10 µm) during the course of clot contraction.
When an adherent platelet spread over a single fibrin fiber, its
filopodia stretched along the fiber axis (Fig. 1a). Initially, the fiber
remained stationary until the filopodium began to contract, at
which point it was pulled by the filopodium, such that the
attached fiber was bent sharply, so that it formed a kink and
moved toward the main part of the cell. Finally, the displaced
fiber became deformed, crumpled and after about t= 700 s got
incorporated into a bundle of compacted fibrin fibers (Fig. 1a).
Subsequently, another filopodium bound to the same fiber and
pulled on it, such that the platelet pulled with a hand-over-hand
motion, like pulling on a rope. To quantify the displacement of
fibrin fibers powered by platelet filopodia, we measured the length
of each kink of individual fibrin fibers and the rate of fiber
shortening (Fig. 1b, c). The average length of fibrin kinks (1.6±
0.5 µm, mean± SD, n= 42) was ~ 1.7 times smaller than the
average length of filopodia (Fig. 1c) (2.7± 1.1 µm, n= 300),
indicating that each filopodium contracted partially (by a part of
its length). As a result of filopodia pulling, platelet-attached fibrin
fibers shortened (Fig. 1b, inset) at a mean rate of 0.003± 0.002
µm/s (n= 30). The dynamic interaction of a platelet and a single
fibrin fiber is shown in the Supplementary Movies 1, 2.
The observed platelet-fibrin dynamic rearrangements have
substantial differences from the behavior of fibroblasts moving on
and reshaping collagen in the extracellular matrix17. Although
fibroblasts also pull hand-over-hand on collagen fibers and kink
them, platelets use thin and short filopodia, while fibroblasts bind
to collagen via larger protrusions or lamellipodia and do not
generally contract the matrix18. In contrast to fibroblasts, platelets
do not release the displaced fibers, rather remaining attached to
them and compacting fibrin fibers locally into bundles and
clusters. In addition, the force field generated by platelets was
shown to be isotropic19, whereas fibroblasts generate an
anisotropic force field, which enables them to migrate actively17.
Other additional differences can be found in Supplementary
Note 1. Therefore, the platelet-fibrin interactions comprise
distinct and understudied cell motility and matrix remodeling
mechanisms.
Platelets cause compaction of the fibrin network. In addition to
single cell/single fiber interactions, we observed larger scale fibrin-
platelet associations (over ~ 100 µm), in which a platelet aggre-
gate attached via filopodia to multiple fibers (Fig. 1e, Supple-
mentary Movie 3). Remarkably, platelets were able to stretch
filopodia across the gap between the main body of the cell and the
neighboring fibers and pull on the fibers transversely, re-orienting
them toward the cell. Contraction of the filopodia caused the
fibers’ displacement followed by their compaction and even
bundling. Sequential extension-retraction of platelet filopodia
resulted in accumulation of the fibrin mass that was progressively
more and more co-localized with the platelets. Similar to con-
traction of a single fiber, the platelet(s) remained attached to the
bundle of compacted fibrin fibers with multiple fibers radiating
outward from the cell or cell aggregate.
Filopodia extension and retraction can be considered as the
elementary event of continuous clot contraction. Repetitive
extension and retraction of filopodia caused an increasing fiber
displacement and progressive accumulation/compaction of fibrin
fibers co-localized with platelets. Thus, the main biomechanical
mechanism of fibrin network remodeling is caused by the platelet
filopodia-driven extension/retraction steps. To quantify the
dynamics of fibrins compaction, we assessed the area of fibrin
co-localized with platelets at different time points (Fig. 2). The
mean total area of platelet-attached fibrin increased dramatically
during first 30 min of contraction, indicating a 10-fold increase
compared to the initial amount of platelet-associated fibrin
(Fig. 2b). The average area of platelet-bound fibrin after
normalization per platelet also increased with time and reached
on average 5.4 µm2/cell after 40 min of contraction. Inhibition of
platelet contractile proteins by the myosin inhibitor blebbistatin
significantly reduced fibrin compaction and resulted in only a
twofold increase of the mean total area of platelet-co-localized
fibrin, reaching 2.5 µm2/cell (Fig. 2c). Blockage of αIIbβ3-fibrin
interaction with abciximab precluded fibrin compaction (Supple-
mentary Fig. 1).
Both single platelets and platelet aggregates actively performed
fibrin remodeling. To see if platelet aggregation affected fibrin
remodeling, we measured the fraction of fibrin co-localized with
single platelets and with platelet aggregates (Fig. 2d). During clot
contraction, the fraction of fibrin bundles compacted by platelet
aggregates gradually increased from zero and reached 33± 8%
(n= 60) at the final stage of contraction, while the relative
fibrin mass that occupied an area smaller than a single platelet
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(SSP= 9 µm2) dropped from 100% to 33± 9% (n= 110). As the
maximum size of a compacted fibrin bundle is determined by the
size of an associated platelet aggregate, our findings suggest that
platelet aggregation enhances remodeling of fibrin matrix and
results in formation of larger clumps of densified (or compacted)
fibrin as compared to fibrin accumulated by single platelets. Since
formation of compacted fibrin is driven by platelet actomyosin
contractile machinery, a platelet aggregate dissipates more energy
on pulling and compacting fibrin than an individual platelet by
deforming a larger number of fibrin fibers. Therefore, platelet
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Fig. 1 Time-lapse images of contracting platelets that cause bending, kinking, and local accumulation of a single fibrin fiber. a Top row: a platelet or a small
platelet aggregate (green) attaches to a fiber (red) and spreads filopodia along the fiber axis that contract, inducing a fiber kink and pulling the fiber, compacting
it into a dense fibrin knot or coil. For details see Supplementary Movie 1. a Middle row: platelet transformations, including attachment of filopodia to a fiber,
spreading and contraction (corresponding to a, top row). a Bottom row: platelet-induced structural changes in a fibrin fiber. The inset (t= 120 s) shows formation
of a kink. Arrows indicate filopodia attached to a fiber, including the kink. b Length distributions of the fiber kinks, LK (n= 42) and platelet filopodia, LP (n=
300). The bars represent experimental numbers and the curves are log-normal fits. Inset: shortening of a fibrin fiber (black dots) and the shortening rate (blue
dotted line) caused by platelet contraction (mean± SD, n= 30). t*, t** are the microscopic phase transition times separating different regimes of filopodia
shortening. c A zoomed fiber kink of a length LK. d Filopodia with lengths defined as LP; both parameters presented in b. e Serial images of a contracting platelet
reveal reorganization and compaction of fibrin fibers surrounding the cell. Top row: combined fibrin and platelet images; middle row: fibrin network only; bottom
row: platelet only. Arrows indicate the platelet’s filopodia attaching to and pulling on fibrin fibers. (see Supplementary Movie 3 for the full sequence at high
magnification and Supplementary Movie 4 for an individual platelet filopodium undergoing contraction)
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aggregates become more efficient in fibrin remodeling at the later
stages of clot contraction forming large patches of compacted
fibrin.
Secondary clustering and fusion of fibrin-attached platelets.
Examination of the time-lapse confocal images of the contracting
platelet-fibrin meshwork revealed secondary platelet clustering as
a result of close spatial approximation of the neighboring fibers
that bear attached platelets (Fig. 3a, Supplementary Movies 4, 5.
As soon as platelets started to compact or densify fibers by pulling
on them, either longitudinally or transversely, the distance
between the fibrin-attached cells shortened and platelets even-
tually merged into a larger cellular clump or aggregate (Supple-
mentary Fig. 2).
To quantify the phenomenon of platelet clustering, we
examined the distribution of platelet-specific fluorescent areas
in the z-projection obtained from 3D confocal time-series of the
contracting platelet-fibrin meshwork. Although the peak of the
platelet size distribution ( ~ 6 µm2) did not change during
contraction (Fig. 3b), the larger cell associations in the tail of
the histogram (Fig. 3b, inset) displayed an increase of average size
(Fig. 3c) from 30.2± 3.6 to 40.9± 18.8 µm2 (P= 0.008, a two-
tailed Mann−Whitney test). This secondary enlargement of
platelet aggregates incorporated into fibrin likely results in
generation of a higher contractile force that would promote clot
contraction at the later stages.
Structure-based kinetics of clot contraction. Next, we correlated
the time-dependent structural changes with the overall kinetics of
clot contraction. Vertical z-projections of confocal images of a
fibrin network (186 µm× 186 µm× 30 µm) collected during clot
contraction indicated that fibrin density increased with time
(Fig. 4a, Supplementary Movies 6−8), as measured by the fibrin
fluorescence intensity per square unit (Fig. 4b). This kinetic curve
analyzed using the first derivative, or velocity, revealed three
distinct phases in clot contraction named “pre-contraction” or lag
period (phase P1), “active contraction” (phase P2), and “final
contraction” (phase P3), each characterized by duration and a rate
constant. The average duration of P1 was t1= 5.0± 1.2 min, P2
lasted t2= 28.0± 1.2 min followed by P3 with t3> 30min. The
corresponding rate constants were k1= 1.07± 0.05/s;
k2= 0.01± 0.005/s; k3= 0.004± 0.002/s.
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Fig. 2 Platelet-induced fibrin compaction. (a, left): a confocal image of platelets (green) and fibrin (red); (a, center): fibrin fibers and patches (compacted
fibrin); (a, right): fibrin co-localized with platelets. Compaction of fibrin by a single cell (SSP) and by two platelet aggregates (SPA) is shown; scale bar: 3 μm.
b, c Changes in the total area of platelet-associated fibrin normalized to its initial value b and the mean absolute area of platelet-co-localized
fibrin (c) during the course of clot contraction (mean± SEM). d Relative portion of fibrin material compacted by platelet aggregates, mean± SEM, n> 200.
The analyzed volume size is 217 µm× 217 µm× 34 µm. e, f Confocal images of a fibrin network in a PRP-clot formed and allowed to contract in the
absence (e) and presence (f) of blebbistatin (300 µM). Scale bar: 30 μm
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To determine the effects of inhibition of myosin IIA and fibrin-
αIIbβ3 binding on the observed kinetics, we examined changes in
clot contraction in the presence of blebbistatin, a selective
inhibitor of myosin II, or abciximab, a specific antagonist of the
platelet integrin αIIbβ3. Blebbistatin caused a decrease in the rate
and extent of fibrin densification, which dropped several-fold at
the final phase of contraction (Fig. 4c, d). The delayed network
densification of the fibrin network correlated with significantly
reduced compaction of fibrin fibers (Fig. 2d-f). Addition of
abciximab to the contracting clot also dramatically reduced the
degree of fibrin densification and no compaction of fibers by
platelets was observed (Supplementary Fig. 1).
Mechanics-based kinetics of clot contraction. The integral
structural changes of the contracting fibrin network were corre-
lated with dynamic measurements of the contractile stress gen-
erated by the entire clot. The stress generated by the clot was
measured in a rheometer as the stress on the two horizontal plates
during isometric contraction (Methods section). The time course
of changes in the contractile stress largely concurred with the
time-dependent structural changes. A very gradual initial increase
in the contractile stress turned to asymptotic behavior at the end
of contraction (Fig. 4e, Supplementary Movies 9−11). However,
the kinetic analysis using time peaks of the first derivative
revealed four distinct phases with the second (P2A) and third
(P2B) sub-phases showing up as one phase (P2) in the densifica-
tion curve (Fig. 4f). The borders between the phases were at t1=
3.9± 0.1 min, t2= 11.8± 0.1 min, t3= 31.5± 0.1 min, which were
close to the transition times observed for fibrin densification
(Fig. 4b). The corresponding compression or loading rates were
5.6± 1.3 Pa/min, 4.3± 0.3 Pa/min, 3.0± 1.2 Pa/min, and 0.6±
0.3 Pa/min. Remarkably, the single-fiber contraction rates
(Fig. 1b, inset) signify local minima around t*= 4 min and t** =
14 min, which correspond to the P1−P2 and P2A−P2B phase
transition times obtained from macroscopic whole clot kinetics
measurements20. Because platelet contraction and fibrin network
remodeling are the key elements of the entire process of clot
contraction, the observed correspondence between the phases
determined at the micro-scales and macro-scales suggests that the
multiphasic behavior observed at the whole clot level originates
from the time-dependent functional mechanisms at the level of
single platelet/single fiber interactions.
The mechanical properties of the contracting clots were also
affected by the presence of myosin II and αIIbβ3 inhibitors. Thus,
inhibition of platelet myosin II attenuated the normal stress
threefold, while blocking αIIbβ3-fibrin binding drastically reduced
the contractile stress, which fluctuated around zero (Fig. 4e). The
storage and loss moduli in the presence of abciximab were
decreased significantly compared to non-inhibited clot contrac-
tion or inhibition of platelet myosin II (Fig. 4g, h).
The contractile force generated by a single platelet can be
estimated as the integral force pulling on the rheometer plates
divided by the number of platelets in the clot volume. Such a
calculation yielded a force of ~ 0.3−1.7 nN per platelet, which is in
agreement with the forces 0.3−2.1 nN measured by others12–14, 21.
These numbers are smaller than the force generated by a single
platelet of 29−34 nN15, 19. This discrepancy may be attributed to
the multi-directional force generated by platelets in bulk
compared to a single cell, reorganization of actin in merging
cells22 or variations in cell response to matrix stiffness23.
Clot shrinkage and spatial non-uniformity of contraction. To
establish a connection between microscale cell motion and
alterations of the fibrin network bulk structural properties, we
examined the spatial displacement of single platelets and platelet
ensembles over time during clot contraction. Tracking individual
cells in confocal 3D stacks enabled us to reconstitute a 3D spatial-
temporal displacement field and derive clot volume changes for
each phase of contraction (Fig. 5). We assessed the deformation
of the fibrin network by platelets in terms of the volumetric strain
ϵ ¼ R t0
R
V∇  udvdτ, where u is a platelet displacement rate field
measured by tracking individual platelets incorporated into a 3D
fibrin network, t is the time of contraction, and V is the volume of
the clot domain.
The mean displacement rate (“platelet speed”) decreased
gradually with time and varied from 0.014± 0.009 µm/s at the
beginning of contraction to 0.007± 0.004 µm/s at 40 min of clot
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Fig. 3 Clustering of the fibrin-attached neighboring platelets. a Serial confocal images showing formation of secondary platelet clusters due to
approximation of platelet-bearing fibrin fibers during clot contraction. Platelets are green and fibrin is red. Scale bar: 5 μm. For the entire sequence, see
Supplementary Movies 5, 6. b Platelet area distribution in a contracting clot at different time points with the inset showing the distribution of the larger
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contraction (Fig. 5c). Inhibition of platelet myosin IIA-actin
complex and blocking αIIbβ3 both resulted in reduction of the
platelet moving speed down to its constant values 0.004± 0.003
µm/s and 0.005± 0.002 µm/s, respectively. The calculated volu-
metric strain for “pre-contraction” (phase P1), “active contrac-
tion” (phases P2), and “final contraction” (phase P3) indicated a
significantly higher volume decrease (up to 10 times) in the
absence of inhibitors that reached 27± 2.7% during the final
contraction phase (P3) (Fig. 5d). In the presence of blebbistatin
and abciximab, the clot volume decreased by 7.7± 2.4% and 4.2
± 0.3%, respectively (Fig. 5d). Thus, inhibition of αIIbβ3-mediated
platelet-fibrin interactions by abciximab had a greater inhibitory
effect on clot contraction dynamics than the suppression of
myosin IIA by blebbistatin.
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To examine the spatio-temporal non-uniformity in the clot
contraction rate, clots were formed on a detergent-treated glass
surface (Methods section) to prevent fibrin attachment and to
allow for unconstrained movement/shrinkage of the clot during
contraction. Time-lapse z-stack confocal imaging of the platelet-
fibrin meshwork revealed drastic differences in the speed of
translocating platelets at the edge of the contracting clot moving
inwards and inside the clot (Fig. 6a, b). The mean speed of
platelets near the edge of the clot was 0.020± 0.018 µm/s, while
platelets in the clot interiors moved with an average speed of
0.009± 0.006 µm/s (Fig. 6c). The speed at the clot edge varied
from 0.001 to 0.23 µm/s, while in the interior of the clot the speed
ranged from 0.001 to 0.05 µm/s (Fig. 6d). Hence, spatial
anisotropy of contracting clots is due to the faster moving edges
and less mobile clot’s interior domains. Such a difference in the
speed of platelet displacement can be explained using a
phenomenological model of a contracting clot (Supplementary
Note 2). According to the model, platelets remain stationary in
the center of a contracting clot, while the rate of movement
increases toward the edge of the clot. The quantitative
characteristics of clot contraction are provided in Supplementary
Table 1.
Discussion
Contraction is a final stage of blood clot maturation that
strengthens hemostatic clots, enhances wound healing and
restores blood flow past otherwise obstructive thrombi. The
physical mechanisms of clot contraction have remained
unknown, although certain correlations between blood clot cel-
lular composition and clot contraction mechanics were identi-
fied1. The existing tentative ideas of platelet-fibrin interactions
Fig. 4 Structural and mechanical contraction kinetics of PRP-clots. a Serial confocal images showing time-dependent densification of the fibrin network;
Scale bar: 60 μm. b Dynamic fibrin fluorescence intensity per square micrometer as a measure of fibrin densification (black solid line) characterized by three
phases determined by the local extremes of the first derivative (blue dashed line and vertical dashed borders between the phases). The phase designations
shown here correspond to the phases P1−P4 shown in Fig. 1b. c Fibrin densification as a function of time in the absence and presence of blebbistatin (300
µM) and abciximab (100 µg/ml) (mean ± SD, n = 3). d Fibrin fluorescence intensity (fibrin density) at the end of contraction in the absence and presence
of blebbistatin (300 µM) and abciximab (100 µg/ml) (mean± SD, n= 3, ****P< 0.0001, a two-tailed Mann−Whitney test). e Dynamic contractile stress
generated by the platelet-fibrin meshwork in the absence and presence of 100 µg/ml abciximab, a specific antagonist of the platelet receptor integrin
αIIbβ3 (averaged kinetic curves, n= 3, mean± SD). f The kinetic curve shown in e has four phases (P1, P2A, P2B, and P3) defined as in b. The first phase, P1,
corresponds to the pre-contraction stage with the rate constant k1; P2A and P2B comprise the fastest phases with the rate constants k2 and k3, respectively;
and P3 is the final contraction phase with the rate constant k4. g, h The storage and loss moduli of fully contracted PRP-clots (50min) in the absence and
presence of blebbistatin (300 µM) and abciximab (100 µg/ml) (n= 3, mean± SD, ****P< 0.0001, a two-tailed Mann−Whitney test)
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Fig. 5 Deformation of the platelet-fibrin meshwork during contraction quantified using platelet displacement as a marker indicative of local strain.
a, b Representative images of a three-dimensional platelet displacement field of a contracting clot; a top view, fibrin (red), platelet (green), and platelet
displacement vectors are shown; b perspective view, platelets (green) with their displacement vectors are visualized. The clot volume analyzed was 217
µm× 217 µm× 34 µm. c, d Changes of the platelet velocity during clot contraction c and clot volume reduction d in the absence and presence of blebbistatin
(300 µM) and abciximab (100 µg/ml) (mean± SD, 310 platelets analyzed in three clots). Statistical significance shown between the volumetric strains of
contracted clots in the absence and presence of blebbistatin or abciximab; P< 0.05, Mann−Whitney U-test
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can be segregated into several conceptual groups. The first one is
based on the assumption that platelets reach out with their filo-
podia to combine with and attach to fibrin fibers, pulling the
fibrin mesh toward the platelets24. In the second scenario, filo-
podia are assumed to perform sweeping movements that gather
in and compress fibrin fibers25. The third idea is based on platelet
−platelet interactions via extended filopodia that join adjacent
cells26, after which the surface of the aggregating cells is zippered
together, thus compressing fibrin fibers inside26. Until now there
has been no convincing evidence for any of these scenarios, since
they are based on static electron microscopy or light microscopy
images, so the physical actions of the dynamic platelet-fibrin
interplay could not be observed.
Our results reveal that extension-retraction of platelet filopodia
is a basic function needed for transmitting platelet contractile
force and re-arranging the fibrin matrix, which represents a novel
function for filopodia, since they have generally been thought to
be the cell’s sensory and guiding organelles. These data are in
agreement with previous studies suggesting that platelet filopodia
are functionally important in (patho)physiological processes such
as tissue healing, development, dorsal closure27–31, phagocy-
tosis32, and cancer33. Yet, in contrast to our paper, none of these
studies provided a cellular mechanism for these effects. In a more
general context, the important physiological functions of cellular
filopodia were shown to be necessary for tissue patterning,
establishment of cell−cell junctions, haptotaxis, and matrix
sensing34.
Our study provides quantitative structural details of how
contracting platelets cause clot volume shrinkage accompanied by
dramatic structural alterations of the platelet-fibrin meshwork.
We found that activated platelets bend and shorten individual
fibrin fibers via their filopodia that undergo sequential extension
and retraction, as if pulling hand-over-hand on a rope. Platelets
also induce compaction of fibrin fibers into platelet-attached
agglomerates. As a result of simultaneous pulling on multiple,
closely spaced fibrin fibers, platelets pull themselves closer to each
other and form secondary clusters larger than the initial aggre-
gates. Contracting platelets actively remodel the fibrin network by
increasing its density followed by enhanced clot stiffness. Kinetic
analysis of the time course of structural and mechanical transi-
tions revealed a multiphasic behavior with at least three distinct
phases that differ in duration and rate constants. All the observed
changes were reduced or abrogated in the presence of specific
inhibitors of non-muscle myosin IIA (blebbistatin) and the pla-
telet integrin αIIbβ (abciximab), indicating that actomyosin-driven
cell contractility and integrin-fibrin mediated platelet-fibrin
interactions are crucial for contraction of blood clots. Finally,
blood clot contraction was found to be a spatially non-uniform
process with faster compression of the clot edge and a delayed
deformation of the clot interior. Altogether, the results provide a
quantitative structural basis for the mechanobiology of clot
contraction at various spatial scales from a single cell/single fiber
level up to the network and macroscopic levels. Our results
obtained on platelet-induced contraction of the filamentous fibrin
network are of fundamental importance because they provide a
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Fig. 6 Non-uniform deformation of platelet-fibrin meshwork during clot contraction. Clots were formed on a Triton X-100 pre-coated surface to allow for
unconstrained contraction of the clot edges in both vertical and horizontal directions. a Platelet-fibrin mesh z-projections are shown for three different time
points during clot contraction and reveal inward movement of the clot edge (white arrow); scale bar: 40 μm. b Three-dimensional (3D) tracking of individual
platelets embedded into the fibrin network allow visualization of the 3D platelet displacement field; Scale bar: 40 μm. c A representative contour plot of the
mean platelet speed inside a clot (20 µm from the bottom) based on the reconstituted 3D platelet displacement field. The color bar shows the mean speed
of platelet displacement (µm/s). d Changes of the platelet moving speed with time during clot contraction, indicating higher speed values at the edge of
contracting clots (310 cells in three clots). Data presented in d show the absolute velocity of platelets identified in the temporal sequence of 3D images
shown in a. For each time point in d, a set of data points shown corresponds to velocities of platelets tracked in a 3D volume of contracted clot provided in
a. As the edge of the clot passes through the view area between 20 and 30min time points, platelets reach their high velocity values corresponding to a
yellow region in the velocity contour plot in c. For the entire sequence of events see Supplementary Movies 7−11
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foundation for understanding the dynamic and complex bio-
mechanical interplay between non-muscle cells and the fibrous
extracellular matrices of various compositions.
Methods
Platelet-rich plasma. Blood was drawn by venipuncture from healthy volunteers
not talking aspirin or other medications known to affect platelet function for at
least 10 days. Informed consent was obtained in accordance with a protocol
approved by the University of Pennsylvania Institutional Review Board. Platelet-
rich plasma (PRP) was prepared from whole blood drawn into 3.8% trisodium
citrate (9:1 v/v). To obtain PRP, the citrated blood was centrifuged at 210×g at 25°C
for 15 min. The platelet count was performed using an automated hematology
analyzer (HemaVet 950FS, Drew Scientific). PRP samples were kept at room
temperature and studied within 4 h after blood collection.
Contracting clots. To visualize distinctly fibrin and platelets in a fluorescent
confocal microscope, Alexa-Fluor 594-labeled human fibrinogen (Molecular
Probes, Grand Island, NY, 40 µg/ml final concentration) and calcein green, AM
(Molecular Probes, 0.2 µg/ml final) were added to PRP samples and incubated for
10 min at 37 °C before initiation of clotting. Clotting was induced by adding CaCl2
(40 mM final concentration) and thrombin (0.75 or 1 U/ml final concentration) to
PRP containing the fluorescent probes. Thirty microliters of samples was quickly
transferred onto 35 × 10 mm PELCO clear wall glass bottom cell culture dishes in
the environmental chamber of the confocal microscope for the time course z-stack
imaging. In some experiments, the glass was pre-coated with 4% (v/v) Triton X-100
in PBS to prevent attachment of fibrin and allow for unconstrained clot contrac-
tion. In inhibitory experiments abciximab (ReoPro; Eli Lilly, Indianapolis, IN,
USA) was added to PRP at 100 µg/ml or blebbistatin (Sigma-Aldrich, St. Louis,
MO, USA) was used at 300 µM (both final concentrations) prior to the fluorescent
probes and incubated for 15 min at 37 °C.
Confocal microscopy of contracting clots. Contracting clots were imaged in a
Zeiss LSM710 laser confocal microscope with Plan Apo ×40 (NA 1.2) water
immersion objective lens to obtain a series of high-resolution 35 µm-thick z-stack
images taken during 30−50 min over the course of clot formation and contraction.
The distance between each z-stack slice was 0.8 µm with a resolution of 1024 ×
1024 pixels. At the end of each clot contraction experiment, a 212.5 µm× 212.5
µm× 103 µm z-stack was taken with a voxel size of 0.2076 × 0.2076 × 0.6896 µm3. A
combination of an argon laser beam with a 488-nm wavelength and a helium-neon
laser beam with a 594-nm wavelength was utilized for confocal microscopy of
fluorescently labeled platelets and fibrin, respectively.
Image analysis and data presentation. The images of contracting clots obtained
with a confocal microscope were analyzed with a number of complementary
software packages to characterize the clots’ structural dynamics. Changes in fibrin
fluorescent intensity, its density and co-localization of fibrin and platelets were
analyzed using the open source Fiji software35. Cubic convolution interpolation
using the TransformJ plugin in the Fiji software was applied to the original con-
focal data to acquire zoomed-in images of platelet filopodia and individual fibrin
fibers shown in Fig. 1c, d. The length measurements presented in Fig. 1b were
based on the original confocal microscopy images using a standard distance
measurements segmented-line tool in Fiji.
The amount of fibrin associated with individual platelets was quantified by
measuring the fibrin area co-localized with a platelet, using a standard co-
localization analysis of the Fiji software. Following acquisition of a co-localized
pixel map and platelet-co-localized fibrin segmented images (Fig. 2a, right inset),
the area of compacted fibrin fragments was measured using a standard Fiji analysis
tool named “Analyze Particles”.
The fraction of fibrin compacted by platelet aggregates was calculated as the
ratio of the total area of compacted fibrin co-localized with platelets having area >
SSP to the overall fibrin amount associated with both single platelets and platelet
aggregates.
Platelets were tracked using Imaris 8.2, visualization and 3D reconstruction
were done in Fiji, Imaris and Volocity, and numerical and graphical data analysis
and presentation were done in MATLAB and GraphPad Prism 6.
Rheometry of contracting clots. We used a rotational rheometer (ARG2; TA
Instruments, New Castle, DE, USA) to quantify changes in viscoelastic properties
of PRP-clots during contraction over the time course of 50 min. A 20-mm flat
parallel top rotating plate and a fixed bottom plate were employed as the test
geometry. PRP samples were activated with CaCl2 and thrombin as described
above, placed in a 400 µm-gap between the top and bottom plates and a low
oscillatory shear strain (1%, 1 Hz) was applied. The elastic and viscous properties of
the clot were characterized by their storage (G′) and loss (G″) moduli, respectively.
In addition, the contractile force generated by the platelet-fibrin matrix was
measured as a negative normal (pulling) force applied to the rheometer plates. To
prevent sample drying at the clot-air interface, a layer of silicone oil was applied at
the edge of the clot.
Analysis of clot contraction kinetics. Kinetic analysis was done by calculating the
first derivative of the curves reflecting changes of fibrin fluorescence intensity over
time and normal force curves. Peaks of the first derivative enabled us to segregate
the kinetic curves into distinct contraction phases characterized by discrete rate
constants. Curve fitting was done using a polynomial function over the time course
of clot contraction.
Statistical analysis. For clot contraction assays, statistical analysis using 40 z-
stacks of confocal microscopic images for a single clot sample in parallel multiple
sample measurements was conducted. All data were obtained from at least three
independent measurements and were expressed as mean± SD or mean ± SEM as
indicated. Additional information about the platelet sample size is provided in the
Supplementary Table 1. Statistical significance (defined as P< 0.05) was calculated
using a two-sided Mann–Whitney U-test.
Data availability. All relevant data are available from the authors.
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